Paper31169331
Vascular endothelial growth factor (VEGF) impairs the motility and immune function of human mature dendritic cells through the VEGF receptor 2-RhoA-cofilin1 pathway.
Long J and 14 others. Cancer Sci, 2019. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. Vascular endothelial growth factor (VEGF) impairs the motility and immune function of human mature dendritic cells through the VEGF receptor 2-RhoA-cofilin1 pathway. Papers, record 31169331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31169331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Vascular endothelial growth factor (VEGF) impairs the motility and immune function of human mature dendritic cells through the VEGF receptor 2-RhoA-cofilin1 pathway.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Actin Depolymerizing Factors | Major topic |
| Cell Movement | Major topic |
| Dendritic Cells | Major topic |
| Signal Transduction | Major topic |
| Vascular Endothelial Growth Factor A | Major topic |
| Vascular Endothelial Growth Factor Receptor-2 | Major topic |
| rhoA GTP-Binding Protein | Major topic |
| Cells, Cultured | |
| Cytokines | |
| Human Umbilical Vein Endothelial Cells | |
| Humans |
Source PubMed
Grants14
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 31771014 | National Natural Science Foundation of China | PubMed | ||
| 31660258 | National Natural Science Foundation of China | PubMed | ||
| 31860262 | National Natural Science Foundation of China | PubMed | ||
| 11762006 | National Natural Science Foundation of China | PubMed | ||
| 2015M582747XB | China Postdoctoral Science Foundation | PubMed | ||
| 210196 | Key Project of the Ministry of Education of China | PubMed | ||
| 2018-1412 | Science and Technology Foundation of Guizhou Province | PubMed | ||
| 2019-1266 | Science and Technology Foundation of Guizhou Province | PubMed | ||
| 2019-2787 | Science and Technology Foundation of Guizhou Province | PubMed | ||
| 2016-5676 | Science and Technology Foundation of Guizhou Province | PubMed | ||
| 2017-5718 | Science and Technology Foundation of Guizhou Province | PubMed | ||
| 2015-4021 | Science and Technology Innovative Talent Team of Guizhou Province | PubMed | ||
| 2015-04 | 2011 Collaborative Innovation Program of Guizhou Province | PubMed | ||
| KY-2016-031 | Cell and Gene Engineering Innovative Research Groups of Guizhou Province | PubMed |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29365205 | The siren song of bevacizumab: swan song or clarion call? | Neuro Oncol | 2018 | https://conductscience.org/library/papers/29365205 | PubMed |
| 2 | 21436444 | Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. | Science | 2011 | https://conductscience.org/library/papers/21436444 | PubMed |
| 3 | 18596824 | VEGF-targeted therapy: mechanisms of anti-tumour activity. | Nat Rev Cancer | 2008 | https://conductscience.org/library/papers/18596824 | PubMed |
| 4 | 22437871 | Cancer immunotherapy via dendritic cells. | Nat Rev Cancer | 2012 | https://conductscience.org/library/papers/22437871 | PubMed |
| 5 | 31169331 | Vascular endothelial growth factor (VEGF) impairs the motility and immune function of human mature dendritic cells through the VEGF receptor 2-RhoA-cofilin1 pathway. | Cancer Sci | 2019 | https://conductscience.org/library/papers/31169331 | PubMed |
| 6 | 12586633 | VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. | Blood | 2003 | https://conductscience.org/library/papers/12586633 | PubMed |
| 7 | 30464294 | Dendritic cell subsets in T cell programming: location dictates function. | Nat Rev Immunol | 2019 | https://conductscience.org/library/papers/30464294 | PubMed |
| 8 | 16951216 | Vascular endothelial growth factor signaling pathways: therapeutic perspective. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16951216 | PubMed |
| 9 | 28812378 | Bevacizumab in advanced lung cancer: state of the art. | Future Oncol | 2017 | https://conductscience.org/library/papers/28812378 | PubMed |
| 10 | 23000962 | Stimulus-dependent phosphorylation of profilin-1 in angiogenesis. | Nat Cell Biol | 2012 | https://conductscience.org/library/papers/23000962 | PubMed |
| 11 | 15611243 | Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation. | J Immunol | 2005 | https://conductscience.org/library/papers/15611243 | PubMed |
| 12 | 14971041 | Morphological changes during dendritic cell maturation correlate with cofilin activation and translocation to the cell membrane. | Eur J Immunol | 2004 | https://conductscience.org/library/papers/14971041 | PubMed |
| 13 | 9834220 | Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. | Blood | 1998 | https://conductscience.org/library/papers/9834220 | PubMed |
| 14 | 22593798 | Role of the cofilin activity cycle in astrocytoma migration and invasion. | Genes Cancer | 2011 | https://conductscience.org/library/papers/22593798 | PubMed |
| 15 | 20037595 | Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. | Nat Med | 2010 | https://conductscience.org/library/papers/20037595 | PubMed |
| 16 | 27890914 | Dendritic cell migration in health and disease. | Nat Rev Immunol | 2017 | https://conductscience.org/library/papers/27890914 | PubMed |
| 17 | 17898760 | Taking dendritic cells into medicine. | Nature | 2007 | https://conductscience.org/library/papers/17898760 | PubMed |
| 18 | 22136168 | Decisions about dendritic cells: past, present, and future. | Annu Rev Immunol | 2012 | https://conductscience.org/library/papers/22136168 | PubMed |
| 19 | 11564770 | A pivotal role of Rho GTPase in the regulation of morphology and function of dendritic cells. | J Immunol | 2001 | https://conductscience.org/library/papers/11564770 | PubMed |
| 20 | 30410348 | Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy. | Onco Targets Ther | 2018 | https://conductscience.org/library/papers/30410348 | PubMed |
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42495630 | RHOA at the intersection of inflammation-driven and sporadic colorectal cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42495630 | PubMed |
| 42421501 | VEGFC as a prognostic cytokine biomarker linking lymph node metastasis to immune suppression in breast cancer. | Eur Cytokine Netw | 2026 | https://conductscience.org/library/papers/42421501 | PubMed |
| 42135728 | The interplay between p21-activated kinases and tumour-infiltrating dendritic cells and T cells and its implication in pancreatic cancer immunotherapy. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42135728 | PubMed |
| 42023218 | Integrating bulk, single-cell, and spatial transcriptomics to identify a novel pyroptosis-related gene signature for predicting prognosis and tumor immune landscape in triple-negative breast cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42023218 | PubMed |
| 42015329 | Vascular endothelial growth factor (VEGF) biology and its proposed role in rheumatic diseases pathogenesis. | Adv Rheumatol | 2026 | https://conductscience.org/library/papers/42015329 | PubMed |
| 41938478 | A Novel Strategy for Treating Elderly Patients with Advanced Non-Small Cell Lung Cancer: Exploring the Efficacy and Safety of Anlotinib Combined with PD-1/PD-L1 Inhibitors. | Onco Targets Ther | 2026 | https://conductscience.org/library/papers/41938478 | PubMed |
| 41086813 | Dendritic cell immunotherapy advances for solid tumors: Vaccination and modulation. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/41086813 | PubMed |
| 41074600 | COL6A2: A Key Survival-Related Gene and Restricting Antitumor Immunity in Glioblastoma. | Cancer Sci | 2025 | https://conductscience.org/library/papers/41074600 | PubMed |
| 41050088 | Predictive Value of Serum VEGF Levels in Non-Small Cell Lung Cancer: A Review. | Oncol Res | 2025 | https://conductscience.org/library/papers/41050088 | PubMed |
| 40963621 | Hypoxia and activation of hypoxia inducible factor alpha as influencers of inflammatory helper T cells in autoimmune disease - a link between cancer and autoimmunity. | Front Immunol | 2025 | https://conductscience.org/library/papers/40963621 | PubMed |
| 40255905 | Exploring the Role of Cellular Interactions in the Colorectal Cancer Microenvironment. | J Immunol Res | 2025 | https://conductscience.org/library/papers/40255905 | PubMed |
| 40243458 | Fumonisin B1 Exerts Immunosuppressive Effects Through Cytoskeleton Remodeling and Function Attenuation of Mature Dendritic Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40243458 | PubMed |
| 39982231 | Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer Treatment. | Antibodies (Basel) | 2025 | https://conductscience.org/library/papers/39982231 | PubMed |
| 39881005 | Cross-priming in cancer immunology and immunotherapy. | Nat Rev Cancer | 2025 | https://conductscience.org/library/papers/39881005 | PubMed |
| 39115571 | Adenosine A2AR in viral immune evasion and therapy: unveiling new avenues for treating COVID-19 and AIDS. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/39115571 | PubMed |
| 38927447 | Dendritic Cells: A Bridge between Tolerance Induction and Cancer Development in Transplantation Setting. | Biomedicines | 2024 | https://conductscience.org/library/papers/38927447 | PubMed |
| 38550779 | DNA-PKcs Phosphorylates Cofilin2 to Induce Endothelial Dysfunction and Microcirculatory Disorder in Endotoxemic Cardiomyopathy. | Research (Wash D C) | 2024 | https://conductscience.org/library/papers/38550779 | PubMed |
| 38473341 | Dendritic Cells in Cancer Immunology and Immunotherapy. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38473341 | PubMed |
| 38299375 | Bioenergetic and excitotoxic determinants of cofilactin rod formation. | J Neurochem | 2024 | https://conductscience.org/library/papers/38299375 | PubMed |
| 38280470 | VEGF signaling: Role in angiogenesis and beyond. | Biochim Biophys Acta Rev Cancer | 2024 | https://conductscience.org/library/papers/38280470 | PubMed |
Genes30
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31169331
GET https://conductscience.org/api/papers/v1/31169331/references?page=2